
Comparative evaluation of critical concentrationsfor detecting borderline rifampin resistance in Mycobacterium tuberculosis
Original article Chang-Ki Kim1, Hee Jae Huh2, Jeong Su Park3, Taesoung Kim1, Jae Han Sohn1 1Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, 2Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 3Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Corresponding to Chang-Ki Kim, E-mail: psoas95@gmail.com Ann Clin Microbiol 2023;26(4):139-145. https://doi.org/10.5145/ACM.2023.26.4.139Received on 4 December 2023, Revised on 18 December 2023, Accepted on 18 December 2023, Published on 20 December 2023.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Rifampin plays an important role in tuberculosis treatment. In recent years, the introduction of molecular testing techniques has enabled the rapid detection of rifampin resistance, leading to discrepancies
